Beyond the gene: Targeting neuroinflammation in Huntington’s disease

Dr. Sarah Camargos is joined by Dr. Rajeev Kumar to explore early research on targeting neuroinflammation in Huntington's disease. Dr. Kumar delves into the intricacies of the complement cascade, highlighting the pivotal role of C1q as the recognition molecule at the top of this immune system chain reaction and how ANX005 aims to prevent the initiation of the cascade. He further discusses the implications of biomarker advancements and safety protocols in moving towards more effective treatments for Huntington's disease. Read the article. Journal CME is available until June 30, 2027.